Immunology
-
Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes
This article has 38 authors:Reviewed by ScreenIT
-
Preclinical study of a DNA vaccine targeting SARS-CoV-2
This article has 28 authors:Reviewed by ScreenIT
-
Tobacco, but Not Nicotine and Flavor-Less Electronic Cigarettes, Induces ACE2 and Immune Dysregulation
This article has 7 authors:Reviewed by ScreenIT
-
COVID-19 genetic risk variants are associated with expression of multiple genes in diverse immune cell types
This article has 9 authors:Reviewed by ScreenIT
-
Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
This article has 22 authors:Reviewed by ScreenIT
-
Critical Interactions Between the SARS-CoV-2 Spike Glycoprotein and the Human ACE2 Receptor
This article has 7 authors:Reviewed by ScreenIT
-
PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
This article has 28 authors:Reviewed by ScreenIT
-
Hydroxyzine inhibits SARS-CoV-2 Spike protein binding to ACE2 in a qualitative in vitro assay
This article has 3 authors:Reviewed by ScreenIT
-
Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
This article has 17 authors:Reviewed by ScreenIT
-
A key linear epitope for a potent neutralizing antibody to SARS-CoV-2 S-RBD
This article has 38 authors:Reviewed by ScreenIT